Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Viridian Therapeutics, Inc.\DE (VRDN) Asset Utilization Ratio (2016 - 2025)

Viridian Therapeutics, Inc.\DE (VRDN) has 12 years of Asset Utilization Ratio data on record, last reported at 0.12 in Q3 2025.

  • For Q3 2025, Asset Utilization Ratio rose 27344.94% year-over-year to 0.12; the TTM value through Sep 2025 reached 0.12, up 27344.94%, while the annual FY2024 figure was 0.0, 27.8% down from the prior year.
  • Asset Utilization Ratio reached 0.12 in Q3 2025 per VRDN's latest filing, up from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.12 in Q3 2025 and bottomed at 0.0 in Q4 2024.
  • Average Asset Utilization Ratio over 5 years is 0.01, with a median of 0.0 recorded in 2022.
  • Peak YoY movement for Asset Utilization Ratio: tumbled 96.6% in 2021, then soared 27344.94% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.01 in 2021, then crashed by 70.98% to 0.0 in 2022, then tumbled by 81.06% to 0.0 in 2023, then crashed by 47.97% to 0.0 in 2024, then surged by 30513.65% to 0.12 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.12 in Q3 2025, 0.0 in Q4 2024, and 0.0 in Q3 2024.